Journal of Clinical Endocrinology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Commentary - Journal of Clinical Endocrinology Research (2025) Volume 8, Issue 1

The multifaceted role of the renin-angiotensin-aldosterone system in cardiovascular physiology.

Madhavan Nampoothiri *

Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal, India

Corresponding Author:
Madhavan Nampoothiri
Department of Pharmacology
Manipal College of Pharmaceutical Sciences, Manipal, India
E-mail:
madhavan1994@gmail.com

Received: 05-Apr-2024, Manuscript No. AAJCER-24-131481; Editor assigned: 07-Apr-2024, AAJCER-24-131481 (PQ); Reviewed: 20-Apr-2024, QC No. AAJCER-24-131481; Revised: 07-Apr-2025, Manuscript No. AAJCER-24-131481 (R); Published: 14-Apr-2025, DOI: 10.35841/AAJCER.8.1.182

Citation: Nampoothiri M. The multifaceted role of the renin-angiotensin-aldosterone system in cardiovascular physiology. J Clin Endocrinol Res. 2025;8(1):182

Visit for more related articles at Journal of Clinical Endocrinology Research

Keywords

RAAS, Cardiovascular homeostasis, Angiotensin-converting enzyme, Ang II, Angiotensin receptor blockers.

Introduction

The RAAS is a complex hormonal cascade that plays a central role in regulating blood pressure, fluid balance, and electrolyte homeostasis. It consists of several key components, including renin, angiotensinogen, Angiotensin-Converting Enzyme (ACE), Angiotensin II (Ang II), and aldosterone, each of which contributes to the regulation of cardiovascular function through distinct mechanisms. In addition to its classical role in blood pressure regulation, the RAAS has been implicated in a wide range of physiological processes, including cardiac remodeling, vascular inflammation, and metabolic regulation.

Cardiac function

One of the primary functions of the RAAS is to regulate cardiac function. Ang II, the principal effector peptide of the RAAS, exerts direct effects on cardiac myocytes, promoting myocardial hypertrophy, fibrosis, and contractility. These actions contribute to the development of cardiac remodeling and left ventricular dysfunction, which are hallmark features of heart failure and other cardiovascular diseases. Additionally, aldosterone, a mineralocorticoid hormone synthesized by the adrenal glands, plays a role in sodium retention and potassium excretion, leading to alterations in cardiac ion channels and electrophysiological properties.

Vascular tone

In addition to its effects on cardiac function, the RAAS also plays a critical role in regulating vascular tone and blood pressure. Ang II acts on vascular smooth muscle cells to induce vasoconstriction and increase peripheral resistance, thereby elevating blood pressure. Moreover, Ang II promotes vascular inflammation, oxidative stress, and endothelial dysfunction, contributing to the development of atherosclerosis and hypertension. Aldosterone further enhances vascular tone by promoting sodium reabsorption in the renal tubules, leading to volume expansion and increased blood pressure.

Metabolism

Emerging evidence suggests that the RAAS also influences metabolic processes beyond its classical role in cardiovascular regulation. Ang II and aldosterone have been implicated in the pathogenesis of insulin resistance, dyslipidemia, and obesity, contributing to the development of metabolic syndrome and type 2 diabetes mellitus. Furthermore, activation of the RAAS has been shown to impair glucose uptake, insulin signaling, and lipid metabolism in peripheral tissues, exacerbating metabolic dysfunction and cardiovascular risk.

RAAS plays a multifaceted role in cardiovascular physiology

The Renin-Angiotensin-Aldosterone System (RAAS) is a sophisticated hormonal cascade within the body that serves as a central regulator of various physiological processes. It plays a crucial role in controlling blood pressure, fluid balance, and electrolyte levels. The system involves a series of steps, starting with the release of renin by the kidneys in response to low blood pressure or decreased sodium levels. Renin then acts on angiotensinogen to form angiotensin I, which is subsequently converted into angiotensin II by Angiotensin-Converting Enzyme (ACE). Angiotensin II exerts its effects on blood vessels, causing vasoconstriction and elevating blood pressure. Additionally, it stimulates the secretion of aldosterone from the adrenal glands, which promotes sodium reabsorption and potassium excretion in the kidneys, thereby regulating fluid balance and electrolyte levels. Overall, the RAAS is vital for maintaining cardiovascular homeostasis and is implicated in various pathological conditions when dysregulated.

Conclusion

In conclusion, the RAAS plays a multifaceted role in cardiovascular physiology, influencing cardiac function, vascular tone, and metabolism. Dysregulation of the RAAS contributes to the pathogenesis of various cardiovascular diseases, including hypertension, heart failure, and atherosclerosis. Targeting the RAAS with pharmacological inhibitors, such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs), and mineralocorticoid receptor antagonists, represents a cornerstone of cardiovascular therapy and has been shown to improve clinical outcomes in patients with cardiovascular disease. Further research is needed to elucidate the intricate mechanisms underlying RAAS-mediated cardiovascular effects and to develop novel therapeutic strategies for the prevention and treatment of cardiovascular diseases.

Get the App